← Leaderboards
Ian Ronald Corbin
Ut Southwestern Medical Center
$3,266,102
Attributed
$3,266,102
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $491.1K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,266,102 · 2
By mechanism
R01$3,266,102 · 2
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Amit Singal$17,388,983
- Theodore Willis Laetsch$1,603,413
- Sherwin Kelekar$139,229
- Michael Buszczak$10,005,304
- Anthony J Davis$3,457,151
Others in their field
Other Emerging Leaders on “Liver Neoplasms”
- Amit Singal · Ut Southwestern Medical Center$10,531,964
- Jennifer Cohen Price · University Of California, San Francisco$9,760,604
- Aggrey Semwendero Semeere · University Of California, San Francisco$5,619,408
- Ke Zhang · Northeastern University$5,432,578
- Amaia Lujambio · Icahn School Of Medicine At Mount Sinai$5,368,450
- Kamila Naxerova · Massachusetts General Hospital$5,002,681
Research focus
Liver NeoplasmsMalignant NeoplasmsInjuryLiver FunctionMalignant Epithelial CellMalignant Neoplasm Of LiverFluoroscopyHepatocyteLiverLiver DiseasesIncidenceLow-Density LipoproteinsDoseImage GuidedEngineeringConsumptionCatheterizationExtensive NecrosisHepatic ArteryChemoembolizationDiagnosisFunding OpportunitiesDocosahexaenoic AcidsMolecular
Grant awards (9)
Docosahexaenoic Acid Loaded Low-density Lipoproteins: A Novel Biologic Intervention for Hepatocellular Carcinoma.$491,106
R01 · FY2025 · CA · contact PI
Docosahexaenoic Acid Loaded Low-density Lipoproteins: A Novel Biologic Intervention for Hepatocellular Carcinoma.$415,130
R01 · FY2024 · CA · contact PI
Docosahexaenoic Acid Loaded Low-density Lipoproteins: A Novel Biologic Intervention for Hepatocellular Carcinoma.$436,977
R01 · FY2023 · CA · contact PI
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma$370,575
R01 · FY2021 · CA · contact PI
Image Guided Delivery and Evaluation of Low-Density Lipoprotein- Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma -Diversity Supplement$81,132
R01 · FY2021 · CA · contact PI
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma$370,575
R01 · FY2020 · CA · contact PI
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma$359,457
R01 · FY2019 · CA · contact PI
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma$370,575
R01 · FY2018 · CA · contact PI
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma$370,575
R01 · FY2017 · CA · contact PI